David E. Kemp, MD

Baseline Disability and Poor Functioning in Bipolar Disorder Predict Worse Outcomes: Results From the Bipolar CHOICE Study

January 27, 2016

Thilo Deckersbach, Andrew A. Nierenberg, Melvin G. McInnis, et al

Quetiapine-XR for Acute Bipolar Depression

June 24, 2014

Read the full study whether Quetiapine-XR is superior to placebo in bipolar I or II depression with GAD and other comorbidities.

Keming Gao, Renrong Wu, David E. Kemp, et al

Original Research

Weight Change and Metabolic Effects of Asenapine in Patients With Schizophrenia and Bipolar Disorder

December 24, 2013

David E. Kemp, Jun Zhao, Pilar Cazorla, et al

Original Research

Clinical Utility of Early Improvement to Predict Response or Remission in Acute Mania: Focus on Olanzapine and Risperidone

March 8, 2011

David E. Kemp, Ellyn Johnson, Wei V. Wang, et al

Letter to the Editor

Reply to Likelihood to Be Helped or Harmed Can Assist in Clinical Decision-Making

February 15, 2011

Keming Gao, David E. Kemp, Joseph R. Calabrese

Original Research

Number Needed to Treat to Harm for Discontinuation Due to Adverse Events in the Treatment of Bipolar Depression, Major Depressive Disorder, and Generalized Anxiety Disorder With Atypical Antipsychotics

October 19, 2010

Keming Gao, David E. Kemp, Elizabeth Fein, et al

Original Research

Acute Efficacy of Divalproex Sodium Versus Placebo in Mood Stabilizerâ€“Naive Bipolar I or II Depression: A Double-Blind, Randomized, Placebo-Controlled Trial

August 24, 2010

David J. Muzina, Keming Gao, David E. Kemp, et al

Original Research

Metabolic Syndrome in Patients Enrolled in a Clinical Trial of Aripiprazole in the Maintenance Treatment of Bipolar I Disorder: A Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial

May 4, 2010

David E. Kemp, Joseph R. Calabrese, Quynh-Van Tran, et al

Article

Correlates of Historical Suicide Attempt in Rapid-Cycling Bipolar Disorder: A Cross-Sectional Assessment

July 21, 2009

Keming Gao, Bryan K. Tolliver, David E. Kemp, et al

Original Research

Inflammation and the Phenomenology, Pathophysiology, Comorbidity, and Treatment of Bipolar Disorder: A Systematic Review of the Literature

June 2, 2009

Benjamin I. Goldstein, David E. Kemp, Joanna K. Soczynska, et al

Article

A 6-Month, Double-Blind, Maintenance Trial of Lithium Monotherapy Versus the Combination of Lithium and Divalproex for Rapid-Cycling Bipolar Disorder and Co-Occurring Substance Abuse or Dependence

December 30, 2008

David E. Kemp, Keming Gao, Stephen J. Ganocy, et al

Original Research

Clinical Correlates of Patients With Rapid-Cycling Bipolar Disorder and a Recent History of Substance Use Disorder: A Subtype Comparison From Baseline Data of 2 Randomized, Placebo-Controlled Trials

July 31, 2008

Keming Gao, Marcia L. Verduin, David E. Kemp, et al

Baseline Disability and Poor Functioning in Bipolar Disorder Predict Worse Outcomes: Results From the Bipolar CHOICE Study

Quetiapine-XR for Acute Bipolar Depression

Weight Change and Metabolic Effects of Asenapine in Patients With Schizophrenia and Bipolar Disorder

Clinical Utility of Early Improvement to Predict Response or Remission in Acute Mania: Focus on Olanzapine and Risperidone

Reply to Likelihood to Be Helped or Harmed Can Assist in Clinical Decision-Making

Number Needed to Treat to Harm for Discontinuation Due to Adverse Events in the Treatment of Bipolar Depression, Major Depressive Disorder, and Generalized Anxiety Disorder With Atypical Antipsychotics

Acute Efficacy of Divalproex Sodium Versus Placebo in Mood Stabilizerâ€“Naive Bipolar I or II Depression: A Double-Blind, Randomized, Placebo-Controlled Trial

Metabolic Syndrome in Patients Enrolled in a Clinical Trial of Aripiprazole in the Maintenance Treatment of Bipolar I Disorder: A Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial

Correlates of Historical Suicide Attempt in Rapid-Cycling Bipolar Disorder: A Cross-Sectional Assessment

Inflammation and the Phenomenology, Pathophysiology, Comorbidity, and Treatment of Bipolar Disorder: A Systematic Review of the Literature

A 6-Month, Double-Blind, Maintenance Trial of Lithium Monotherapy Versus the Combination of Lithium and Divalproex for Rapid-Cycling Bipolar Disorder and Co-Occurring Substance Abuse or Dependence

Clinical Correlates of Patients With Rapid-Cycling Bipolar Disorder and a Recent History of Substance Use Disorder: A Subtype Comparison From Baseline Data of 2 Randomized, Placebo-Controlled Trials

ELSEWHERE:

FOLLOW US:

David E. Kemp, MD

Baseline Disability and Poor Functioning in Bipolar Disorder Predict Worse Outcomes: Results From the Bipolar CHOICE Study

Quetiapine-XR for Acute Bipolar Depression

Weight Change and Metabolic Effects of Asenapine in Patients With Schizophrenia and Bipolar Disorder

Clinical Utility of Early Improvement to Predict Response or Remission in Acute Mania: Focus on Olanzapine and Risperidone

Reply to Likelihood to Be Helped or Harmed Can Assist in Clinical Decision-Making

Number Needed to Treat to Harm for Discontinuation Due to Adverse Events in the Treatment of Bipolar Depression, Major Depressive Disorder, and Generalized Anxiety Disorder With Atypical Antipsychotics

Acute Efficacy of Divalproex Sodium Versus Placebo in Mood Stabilizerâ€“Naive Bipolar I or II Depression: A Double-Blind, Randomized, Placebo-Controlled Trial

Metabolic Syndrome in Patients Enrolled in a Clinical Trial of Aripiprazole in the Maintenance Treatment of Bipolar I Disorder: A Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial

Correlates of Historical Suicide Attempt in Rapid-Cycling Bipolar Disorder: A Cross-Sectional Assessment

Inflammation and the Phenomenology, Pathophysiology, Comorbidity, and Treatment of Bipolar Disorder: A Systematic Review of the Literature

A 6-Month, Double-Blind, Maintenance Trial of Lithium Monotherapy Versus the Combination of Lithium and Divalproex for Rapid-Cycling Bipolar Disorder and Co-Occurring Substance Abuse or Dependence

Clinical Correlates of Patients With Rapid-Cycling Bipolar Disorder and a Recent History of Substance Use Disorder: A Subtype Comparison From Baseline Data of 2 Randomized, Placebo-Controlled Trials

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles